Search research articles
Contact Us
Filters
Showing results (111-120 of 536) with videos related to
Page
of 54
Sort By:
Blood
|
April 21, 2012
RNA-dependent inhibition of ribonucleotide reductase is a major pathway for 5-azacytidine activity in acute myeloid leukemia
Josephine Aimiuwu, Hongyan Wang, Ping Chen, et al.
Genes, Chromosomes & Cancer
|
December 11, 2012
New recurrent balanced translocations in acute myeloid leukemia and myelodysplastic syndromes: cancer and leukemia group B 8461
Alison Walker, Krzysztof Mrózek, Jessica Kohlschmidt, et al.
Leukemia Research
|
October 24, 2019
Influence of donor KIR genotypes on reduced relapse risk in acute myelogenous leukemia after hematopoietic stem cell transplantation in patients with CMV reactivation
Ryotaro Nakamura, Ketevan Gendzekhadze, Joycelynne Palmer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 20, 2005
Cellular uptake and intracellular levels of the bcl-2 antisense g3139 in cultured cells and treated patients with acute myeloid leukemia
Guowei Dai, Kenneth K Chan, Shujun Liu, et al.
Pharmaceutical Research
|
March 18, 2009
A LC-MS/MS method for the analysis of intracellular nucleoside triphosphate levels
Ping Chen, Zhongfa Liu, Shujun Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 19, 2008
Patients with acute myeloid leukemia and RAS mutations benefit most from postremission high-dose cytarabine: a Cancer and Leukemia Group B study
Andreas Neubauer, Kati Maharry, Krzysztof Mrózek, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
August 16, 2024
Concurrent versus sequential or no triazole anti-fungal therapy in patients undergoing 7 + 3 plus midostaurin induction for FLT-3 acute myelogenous leukemia
Dat Ngo, Jose Tinajero, Jianying Zhang, et al.
NPJ Systems Biology and Applications
|
March 26, 2024
Transcriptome free energy can serve as a dynamic patient-specific biomarker in acute myeloid leukemia
Lisa Uechi, Swetha Vasudevan, Daniela Vilenski, et al.
British Journal of Haematology
|
August 24, 2019
Venetoclax and hypomethylating agents in TP53-mutated acute myeloid leukaemia
Ibrahim Aldoss, Jianying Zhang, Raju Pillai, et al.
Blood
|
July 5, 2024
Homoharringtonine inhibits the NOTCH/MYC pathway and exhibits antitumor effects in T-cell acute lymphoblastic leukemia
Shanshan Suo, Dandan Zhao, Fenglin Li, et al.
Page
of 54
Search research articles
Search
Showing results (111-120 of 536) with videos related to
Sort By:
Page
of 54
Blood
|
April 21, 2012
RNA-dependent inhibition of ribonucleotide reductase is a major pathway for 5-azacytidine activity in acute myeloid leukemia
Josephine Aimiuwu, Hongyan Wang, Ping Chen, et al.
Genes, Chromosomes & Cancer
|
December 11, 2012
New recurrent balanced translocations in acute myeloid leukemia and myelodysplastic syndromes: cancer and leukemia group B 8461
Alison Walker, Krzysztof Mrózek, Jessica Kohlschmidt, et al.
Leukemia Research
|
October 24, 2019
Influence of donor KIR genotypes on reduced relapse risk in acute myelogenous leukemia after hematopoietic stem cell transplantation in patients with CMV reactivation
Ryotaro Nakamura, Ketevan Gendzekhadze, Joycelynne Palmer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 20, 2005
Cellular uptake and intracellular levels of the bcl-2 antisense g3139 in cultured cells and treated patients with acute myeloid leukemia
Guowei Dai, Kenneth K Chan, Shujun Liu, et al.
Pharmaceutical Research
|
March 18, 2009
A LC-MS/MS method for the analysis of intracellular nucleoside triphosphate levels
Ping Chen, Zhongfa Liu, Shujun Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 19, 2008
Patients with acute myeloid leukemia and RAS mutations benefit most from postremission high-dose cytarabine: a Cancer and Leukemia Group B study
Andreas Neubauer, Kati Maharry, Krzysztof Mrózek, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
August 16, 2024
Concurrent versus sequential or no triazole anti-fungal therapy in patients undergoing 7 + 3 plus midostaurin induction for FLT-3 acute myelogenous leukemia
Dat Ngo, Jose Tinajero, Jianying Zhang, et al.
NPJ Systems Biology and Applications
|
March 26, 2024
Transcriptome free energy can serve as a dynamic patient-specific biomarker in acute myeloid leukemia
Lisa Uechi, Swetha Vasudevan, Daniela Vilenski, et al.
British Journal of Haematology
|
August 24, 2019
Venetoclax and hypomethylating agents in TP53-mutated acute myeloid leukaemia
Ibrahim Aldoss, Jianying Zhang, Raju Pillai, et al.
Blood
|
July 5, 2024
Homoharringtonine inhibits the NOTCH/MYC pathway and exhibits antitumor effects in T-cell acute lymphoblastic leukemia
Shanshan Suo, Dandan Zhao, Fenglin Li, et al.
Page
of 54